Prevention and treatment of hemodialysis-related bloodstream infections

Seminars in Dialysis

Volumn 26, Issue 4, 2013, Pages 476-481

  Camins, Bernard C ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT;

ANTIBIOTIC PROPHYLAXIS; ARTICLE; BACTEREMIA; BLOODBORNE BACTERIUM; CATHETER INFECTION; CHRONIC KIDNEY FAILURE; DEVICE REMOVAL; DRUG EFFECT; FEMALE; HUMAN; INDWELLING CATHETER; ISOLATION AND PURIFICATION; MALE; METHODOLOGY; MICROBIOLOGY; PATIENT SAFETY; RENAL REPLACEMENT THERAPY; RISK ASSESSMENT; TREATMENT OUTCOME;

ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; BACTEREMIA; BLOOD-BORNE PATHOGENS; CATHETER-RELATED INFECTIONS; CATHETERS, INDWELLING; DEVICE REMOVAL; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; PATIENT SAFETY; RENAL DIALYSIS; RISK ASSESSMENT; TREATMENT OUTCOME;

EID: 84880685462     PISSN: 08940959     EISSN: 1525139X     Source Type: Journal    
DOI: 10.1111/sdi.12117     Document Type: Article

References (41)

1. U.S. Renal Data System: USRDS 2008 Annual Data Report: Atlas of End-Stage Renal Disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2008
2. U.S. Renal Data System: USRDS 2009 Annual Data Report: Atlas of End-Stage Renal Disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2009
3. Abbott KC, Agodoa LY: Etiology of bacterial septicemia in chronic dialysis patients in the United States. Clin Nephrol 56(2):124-131, 2001
4. Tokars JI, Light P, Anderson J, Miller ER, Parrish J, Armistead N, et al.: A prospective study of vascular access infections at seven outpatient hemodialysis centers. Am J Kidney Dis 37(6):1232-1240, 2001
5. Taylor GD, McKenzie M, Buchanan-Chell M, Caballo L, Chui L, Kowalewska-Grochowska K: Central venous catheters as a source of hemodialysis-related bacteremia. Infect Control Hosp Epidemiol 19(9):643-646, 1998
6. Taylor G, Gravel D, Johnston L, Embil J, Holton D, Paton S: Prospective surveillance for primary bloodstream infections occurring in Canadian hemodialysis units. Infect Control Hosp Epidemiol 23(12):716-720, 2002
7. Taylor G, Gravel D, Johnston L, Embil J, Holton D, Paton S: Incidence of bloodstream infection in multicenter inception cohorts of hemodialysis patients. Am J Infect Control 32(3):155-160, 2004
8. Stevenson KB, Hannah EL, Lowder CA, Adcox MJ, Davidson RL, Mallea MC, et al.: Epidemiology of hemodialysis vascular access infections from longitudinal infection surveillance data: predicting the impact of NKF-DOQI clinical practice guidelines for vascular access. Am J Kidney Dis 39(3):549-555, 2002
9. Ravani P, Palmer SC, Oliver MJ, Quinn RR, Macrae JM, Tai DJ, et al.: Associations between Hemodialysis Access Type and Clinical Outcomes: A Systematic Review. J Am Soc Nephrol 24(3):465-473, 2013
10. Lynch JR, Wasse H, Armistead NC, McClellan WM: Achieving the goal of the Fistula First breakthrough initiative for prevalent maintenance hemodialysis patients. Am J Kidney Dis 57(1):78-89, 2013
11. Lok CE: Fistula first initiative: advantages and pitfalls. Clin J Am Soc Nephrol 2(5):1043-1053, 2007
12. Peterson WJ, Barker J, Allon M: Disparities in fistula maturation persist despite preoperative vascular mapping. Clin J Am Soc Nephrol 3(2):437-441, 2008
13. Patel PR, Yi SH, Booth S, Bren V, Downham G, Hess S, et al.: Bloodstream Infection Rates in Outpatient Hemodialysis Facilities Participating in a Collaborative Prevention Effort: A Quality Improvement Report. Am J Kidney Dis, 2013 EPub May 10
14. Centers for Disease Control: Reducing bloodstream infections in an outpatient hemodialysis center-New Jersey, 2008-2011. MMWR Morb Mortal Wkly Rep 61(10):169-173, 2012
15. Marschall J, Mermel LA, Classen D, Arias KM, Podgorny K, Anderson DJ, Burstin H, Calfee DP, Coffin SE, Dubberke ER, Fraser V, Gerding DN, Griffin FA, Gross P, Kaye KS, Klompas M, Lo E, Nicolle L, Pegues DA, Perl TM, Saint S, Salgado CD, Weinstein RA, Wise R, Yokoe DS: Strategies to prevent central line-associated bloodstream infections in acute care hospitals. Infect Control Hosp Epidemiol 29(Suppl 1):S22-S30, 2008
16. National Kidney Foundation: III. NKF-K/DOQI Clinical Practice Guidelines for Vascular Access: update 2000. Am J Kidney Dis 37(Suppl 1):S137-S181, 2001
17. Fong IW: Prevention of haemodialysis and peritoneal dialysis catheter related infection by topical povidone-iodine. Postgrad Med J 69(Suppl 3):S15-S17, 1993
18. Levin A, Mason AJ, Jindal KK, Fong IW, Goldstein MB: Prevention of hemodialysis subclavian vein catheter infections by topical povidone-iodine. Kidney Int 40(5):934-938, 1991
19. Lok CE, Stanley KE, Hux JE, Richardson R, Tobe SW, Conly J: Hemodialysis infection prevention with polysporin ointment. J Am Soc Nephrol 14(1):169-179, 2003
20. Sesso R, Barbosa D, Leme IL, Sader H, Canziani ME, Manfredi S, Draibe S, Pignatari AC: Staphylococcus aureus prophylaxis in hemodialysis patients using central venous catheter: effect of mupirocin ointment. JAm Soc Nephrol 9(6):1085-1092, 1998
21. Johnson DW, van Eps C, Mudge DW, Wiggins KJ, Armstrong K, Hawley CM, Campbell SB, Isbel NM, Nimmo GR, Gibbs H: Randomized, controlled trial of topical exit-site application of honey (Medihoney) versus mupirocin for the prevention of catheter-associated infections in hemodialysis patients. J Am Soc Nephrol 16(5):1456-1462, 2005
22. Timsit JF, Schwebel C, Bouadma L, Geffroy A, Garrouste-Orgeas M, Pease S, Herault MC, Haouache H, Calvino-Gunther S, Gestin B, Armand-Lefevre L, Leflon V, Chaplain C, Benali A, Francais A, Adrie C, Zahar JR, Thuong M, Arrault X, Croize J, Lucet JC: Chlorhexidine-impregnated sponges and less frequent dressing changes for prevention of catheter-related infections in critically ill adults: a randomized controlled trial. JAMA 301(12):1231-1241, 2009
23. Camins BC, Richmond AM, Dyer KL, Zimmerman HN, Coyne DW, Rothstein M, et al.: A crossover intervention trial evaluating the efficacy of a chlorhexidine-impregnated sponge in reducing catheter-related bloodstream infections among patients undergoing hemodialysis. Infect Control Hosp Epidemiol 31(11):1118-1123, 2010
24. Yahav D, Rozen-Zvi B, Gafter-Gvili A, Leibovici L, Gafter U, Paul M: Antimicrobial lock solutions for the prevention of infections associated with intravascular catheters in patients undergoing hemodialysis: systematic review and meta-analysis of randomized, controlled trials. Clin Infect Dis 47(1):83-93, 2008
25. Labriola L, Crott R, Jadoul M: Preventing haemodialysis catheter-related bacteraemia with an antimicrobial lock solution: a meta-analysis of prospective randomized trials. Nephrol Dial Transplant 23(5):1666-1672, 2008
26. Landry DL, Braden GL, Gobeille SL, Haessler SD, Vaidya CK, Sweet SJ: Emergence of gentamicin-resistant bacteremia in hemodialysis patients receiving gentamicin lock catheter prophylaxis. Clin J Am Soc Nephrol 5(10):1799-1804, 2010
27. National Kidney Foundation; Clinical practice guidelines for vascular access. Am J Kidney Dis 48(Suppl 1):S176-S247, 2006
28. HICPAC. 2011 Guidelines for the Prevention of Intravascular Catheter-Related Infections 2011 [cited 2013 03/05/2013]; Available from: http://www.cdc.gov/hicpac/bsi/bsi-guidelines-2011.html
29. Maki DG, Ash SR, Winger RK, Lavin P: A novel antimicrobial and antithrombotic lock solution for hemodialysis catheters: a multi-center, controlled, randomized trial. Crit Care Med 39(4):613-620, 2011
30. Eloot S, De Vos JY, Hombrouckx R, Verdonck P: How much is catheter flow influenced by the use of closed luer lock access devices? Nephrol Dial Transplant 22(10):3061-3064, 2007
31. ICU Medical Inc. Advancements in Hemodialysis Technology: Decreasing Catheter-Related Bloodstream Infection (CRBSI) Rates, improving patient outcomes, and reducing cost associated with catheter care. 2012 [cited; Available from: http://www.icumed.com/media/95888/M1-1301_Western_Skies_Dialysis_Center_Tego_Testimonial%20(1).pdf
32. McAfee N, Seidel K, Watkins S, Flynn JT: A continuous quality improvement project to decrease hemodialysis catheter infections in pediatric patients: use of a closed luer-lock access cap. Nephrol Nurs J 37(5):541-544, 2010
33. Mermel LA, Allon M, Bouza E, Craven DE, Flynn P, O'Grady NP, Raad II, Rijnders BJ, Sherertz RJ, Warren DK: Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America. Clin Infect Dis 49(1):1-45, 2009
34. Klevens RM, Edwards JR, Andrus ML, Peterson KD, Dudeck MA, Horan TC: Dialysis Surveillance Report: National Healthcare Safety Network (NHSN)-data summary for 2006. Semin Dial 21(1):24-28, 2008
35. Dopirak M, Hill C, Oleksiw M, Dumigan D, Arvai J, English E, et al.: Surveillance of hemodialysis-associated primary bloodstream infections: the experience of ten hospital-based centers. Infect Control Hosp Epidemiol 23(12):721-724, 2002
36. Hannah EL, Stevenson KB, Lowder CA, Adcox MJ, Davidson RL, Mallea MC, et al.: Outbreak of hemodialysis vascular access site infections related to malfunctioning permanent tunneled catheters: making the case for active infection surveillance. Infect Control Hosp Epidemiol 23(9):538-541, 2002
37. Alexandraki I, Sullivan R, Zaiden R, Bailey C, McCarter Y, Khan A, et al.: Blood culture isolates in hemodialysis vascular catheter-related bacteremia. Am J Med Sci 336(4):297-302, 2008
38. Maya ID, Carlton D, Estrada E, Allon M: Treatment of dialysis catheter-related Staphylococcus aureus bacteremia with an antibiotic lock: a quality improvement report.[see comment]. Am J Kidney Dis 50(2):289-295, 2007
39. Poole CV, Carlton D, Bimbo L, Allon M: Treatment of catheter-related bacteraemia with an antibiotic lock protocol: effect of bacterial pathogen. Nephrol Dial Transplant 19(5):1237-1244, 2004
40. Fernandez-Hidalgo N, Almirante B, Calleja R, Ruiz I, Planes AM, Rodriguez D, et al.: Antibiotic-lock therapy for long-term intravascular catheter-related bacteraemia: results of an open, non-comparative study. J Antimicrob Chemother 57(6):1172-1180, 2006
41. Peterson WJ, Maya ID, Carlton D, Estrada E, Allon M: Treatment of dialysis catheter-related Enterococcus bacteremia with an antibiotic lock: a quality improvement report. Am J Kidney Dis 53(1):107-111, 2009